← Back to Search

Communication Tool for Heart Failure (CHATT Trial)

N/A

Recruiting

Led By Melissa Cousino, PhD

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients 12-24 years old with heart failure symptoms meeting criteria for New York Heart Association (NYHA) Class II - IV heart failure

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 30 minutes (approximately)

Awards & highlights

CHATT Trial Summary

This trial aims to improve how doctors communicate with young people with serious heart conditions, ensuring they are well informed and supported.

Who is the study for?

This trial is for pediatric cardiologists at the University of Michigan and their patients aged 12-24 with moderate to severe heart failure (NYHA Class II - IV). It also includes one parent/caregiver per patient, provided they speak English. Physicians must expect to stay on staff for over a year. Patients with significant cognitive delays or non-English speaking caregivers are excluded.Check my eligibility

What is being tested?

The study is testing 'We Chatt', a communication tool designed to enhance conversations between doctors and young patients with advanced heart disease, against the usual standard care practices in place.See study design

What are the potential side effects?

Since this trial focuses on communication improvement rather than medical treatments, there are no direct physical side effects from participating. However, participants may experience emotional or psychological impacts related to discussing health issues.

CHATT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 12-24 years old with heart failure symptoms classified as NYHA Class II-IV.

CHATT Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 30 minutes (approximately)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~30 minutes (approximately)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes (approximately) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient overall satisfaction with the We Chatt intervention based on the patient survey

Patient/Caregiver overall satisfaction with the We Chatt intervention based on the parent/caregiver survey

Physician overall satisfaction with the We Chatt intervention based on the post clinician survey

Secondary outcome measures

Parent/Caregiver satisfaction with the We Chatt intervention based on the parent/caregiver survey

Patient satisfaction with the We Chatt intervention based on the patient survey

Physician satisfaction with the We Chatt intervention from physicians based on the post clinician survey

+1 more

CHATT Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: We Chatt communication toolExperimental Treatment1 Intervention

Group II: Usual carePlacebo Group1 Intervention

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,798 Previous Clinical Trials

6,378,058 Total Patients Enrolled

25 Trials studying Heart Failure

12,036 Patients Enrolled for Heart Failure

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,840 Previous Clinical Trials

47,852,044 Total Patients Enrolled

206 Trials studying Heart Failure

677,368 Patients Enrolled for Heart Failure

Melissa Cousino, PhDPrincipal InvestigatorUniversity of Michigan

Media Library

We Chatt communication tool Clinical Trial Eligibility Overview. Trial Name: NCT05835063 — N/A

Heart Failure Research Study Groups: Usual care, We Chatt communication tool

Heart Failure Clinical Trial 2023: We Chatt communication tool Highlights & Side Effects. Trial Name: NCT05835063 — N/A

We Chatt communication tool 2023 Treatment Timeline for Medical Study. Trial Name: NCT05835063 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the research team currently enrolling participants into this trial?

"Clinicaltrials.gov's data suggests that this trial, which has not been updated since April 17th 2023, is no longer actively recruiting patients. Nevertheless, there are over seven hundred other medical studies looking for volunteers to take part at the moment."

Answered by AI

What outcomes is this clinical endeavor seeking to accomplish?

"The primary aim of this experiment, over the course of two weeks after intervention, is to measure physician satisfaction with We Chatt through post-clinician surveys. Secondary objectives include assessing parent/caregiver and patient contentment on a scale from 0-10 (with 10 being optimal), as well as quantifying the amount of time clinicians require to finish the We Chat Intervention."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Study to Improve Physician-Youth Communication and Medical Decision Making

Melissa Cousino 2023. "A Study to Improve Physician-Youth Communication and Medical Decision Making". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05835063.